Lithium treatment of affective disorders; effects on the cyclic AMP and inositol phospholipid signalling pathways’

dc.contributor.authorSillence, Daniel J.en
dc.contributor.authorDownes, C. P.en
dc.date.accessioned2015-03-09T11:00:04Z
dc.date.available2015-03-09T11:00:04Z
dc.date.issued1992
dc.description.abstractThe effects of lithium (Li+) on the adenylyl cyclase and inositol phospholipid receptor signalling pathways were compared directly in noradrenergic and carbachol stimulated rat brain cortical tissue slices. Li+ was a comparatively weak inhibitor of noradrenaline-stimulated cyclic AMP accumulation with an IC50 of approx. 20 mM. By contrast, half-maximal effects of Li+ on inositol monophosphate (InsP) accumulation in [3H]inositol labelled tissue slices occurred at about 1 mM. A similar IC50 for Li+ of about 1 mM was also obtained for noradrenaline-stimulated accumulation of CMP-phosphatidate (CMPPA), a sensitive indicator of intracellular inositol depletion, in tissue slices that had been prelabelled with [3H]cytidine. The effect of myo-inositol (inositol) depletion on the prolonged activity of phosphoinositidase C (PIC) was examined in carbachol-stimulated cortical slices using a novel mass assay for InsP. Exposure to a maximal dose of carbachol for 30 min in the presence of 5 mM Li+ caused a 10-fold increase in the level of radioactivity associated with the InsP fraction, but only a 2-fold increase in InsP mass. During prolonged incubations in the presence of both carbachol and Li+ the accumulation of InsP mass was enhanced if 30 mM inositol was included in the medium. The results are compatible with the inositol depletion hypothesis of Li+ action but do not support the concept that adenylyl cyclase or guanine nucleotide dependent proteins represent therapeutically relevant targets of this drug.en
dc.funderMRCen
dc.identifier.citationSillence, D.J. and Downes, C.P. (1992) Lithium treatment of affective disorders; effects on the cyclic AMP and inositol phospholipid signalling pathways. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1138 (1), pp. 46-52en
dc.identifier.doihttps://doi.org/10.1016/0925-4439(92)90150-L
dc.identifier.urihttp://hdl.handle.net/2086/10761
dc.language.isoenen
dc.peerreviewedYesen
dc.projectidMRC PhD studentshipen
dc.publisherElsevieren
dc.researchinstituteLeicester Institute for Pharmaceutical Innovation - From Molecules to Practice (LIPI)en
dc.subjectInositol Phosphatesen
dc.titleLithium treatment of affective disorders; effects on the cyclic AMP and inositol phospholipid signalling pathways’en
dc.typeArticleen

Files

License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
4.2 KB
Format:
Item-specific license agreed upon to submission
Description: